发明名称 |
Treatment of vasculoproliferative conditions |
摘要 |
This invention relates to the field of molecular physiology. Specifically, this invention relates to the prevention and/or treatment of vasculoproliferative conditions, especially those of the eye and in the treatment of tumours that exhibit vascular proliferation. Levels of leucine-rich alpha-2-glycoprotein (Lrg1) have been demonstrated to be increased in patients suffering from such conditions and animal models of such conditions. Antagonists of Lrg1 can be used to prevent and/or treat vasculoproliferative conditions. |
申请公布号 |
AU2010290986(A1) |
申请公布日期 |
2012.04.05 |
申请号 |
AU20100290986 |
申请日期 |
2010.09.06 |
申请人 |
UCL BUSINESS PLC |
发明人 |
GREENWOOD, JOHN;MOSS, STEPHEN;WANG, XIAOMENG |
分类号 |
C07K16/18;C07K14/435;C12N15/113 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|